Novartis | NOVN - Le Chiffre D'Affaires De Vente





Ventes Changement Date
AbbVie USD 16.99B 1.99B 2026-06
Alcon AG USD 2.78B 90M 2026-06
Almirall EUR 602.71M 55.09M 2026-06
Amgen USD 10.1B 1.48B 2026-06
AstraZeneca USD 15.38B 90M 2026-06
Autolus Therapeutics Ltd USD 45.69M 19.47M 2026-06
Bayer EUR 10.87B 2.54B 2026-06
Biogen USD 2.74B 490M 2026-06
Bristol-Myers Squibb USD 12.97B 1.48B 2026-06
Eli Lilly USD 22.97B 3.17B 2026-06
Fresenius EUR 5.95B 210M 2026-06
Fresenius Medical Care EUR 4.86B 250M 2026-06
Genmab DKK 1.16B 259M 2026-06
Gilead Sciences USD 7.8B 800M 2026-06
GlaxoSmithKline GBP 8.41B 781M 2026-06
GRIFOLS EUR 1.87B 170M 2026-06
Hikma Pharmaceutical USD 1.69B 863M 2025-12
J&J USD 25.31B 1.21B 2026-06
Lakefront Biotherapeutics EUR 12.11M 5.61M 2026-06
Lonza CHF 3.58B 63M 2025-06
Merck EUR 5.43B 300M 2026-06
Merck USD 16.6B 310M 2026-06
Novartis USD 14.41B 1.3B 2026-06
Novartis USD 13.11B 750M 2026-03
Novo Nordisk DKK 78.49B 18.33B 2026-06
Orion EUR 521.6M 103.9M 2026-06
Pfizer USD 15.03B 530M 2026-06
Philips EUR 4.36B 450M 2026-06
Recordati EUR 681.35M 32.07M 2026-06
Regeneron Pharmaceuticals USD 4.29B 690M 2026-06
Roche Holding CHF 30.36B 14.71B 2026-06
Sanofi EUR 11.95B 710M 2026-06
UCB EUR 4.25B 764M 2025-12